

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 4.86854905 |
| 2 | locomotory exploration behavior (GO:0035641) | 4.62791762 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.25070559 |
| 4 | sodium ion export (GO:0071436) | 4.14955828 |
| 5 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.91902321 |
| 6 | activation of protein kinase A activity (GO:0034199) | 3.85628177 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.76351051 |
| 8 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.70181205 |
| 9 | regulation of synapse structural plasticity (GO:0051823) | 3.70112034 |
| 10 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.69362933 |
| 11 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.61884073 |
| 12 | glutamate secretion (GO:0014047) | 3.53183955 |
| 13 | barbed-end actin filament capping (GO:0051016) | 3.53183367 |
| 14 | cellular potassium ion homeostasis (GO:0030007) | 3.48219914 |
| 15 | adherens junction assembly (GO:0034333) | 3.47006959 |
| 16 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.44745493 |
| 17 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.43103172 |
| 18 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.42399998 |
| 19 | semaphorin-plexin signaling pathway (GO:0071526) | 3.41270489 |
| 20 | protein retention in ER lumen (GO:0006621) | 3.41083392 |
| 21 | regulation of ARF protein signal transduction (GO:0032012) | 3.40309482 |
| 22 | focal adhesion assembly (GO:0048041) | 3.32923564 |
| 23 | cell-substrate adherens junction assembly (GO:0007045) | 3.32923564 |
| 24 | regulation of early endosome to late endosome transport (GO:2000641) | 3.29700622 |
| 25 | synaptic vesicle exocytosis (GO:0016079) | 3.27298044 |
| 26 | cell-substrate junction assembly (GO:0007044) | 3.27149878 |
| 27 | glycine transport (GO:0015816) | 3.25124526 |
| 28 | neurotransmitter secretion (GO:0007269) | 3.20609178 |
| 29 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.20226925 |
| 30 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.16868045 |
| 31 | negative regulation of fatty acid transport (GO:2000192) | 3.16554060 |
| 32 | basement membrane organization (GO:0071711) | 3.16429684 |
| 33 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.15960529 |
| 34 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.14476113 |
| 35 | regulation of synaptic vesicle transport (GO:1902803) | 3.10555701 |
| 36 | cell communication by electrical coupling (GO:0010644) | 3.07468488 |
| 37 | potassium ion import (GO:0010107) | 3.07214125 |
| 38 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.06662236 |
| 39 | endothelial cell chemotaxis (GO:0035767) | 3.04513167 |
| 40 | activation of Rac GTPase activity (GO:0032863) | 3.04212227 |
| 41 | proline transport (GO:0015824) | 3.02177512 |
| 42 | layer formation in cerebral cortex (GO:0021819) | 3.01446498 |
| 43 | vocalization behavior (GO:0071625) | 3.00193263 |
| 44 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.99645926 |
| 45 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.99448932 |
| 46 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.95699638 |
| 47 | hemidesmosome assembly (GO:0031581) | 2.93217771 |
| 48 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.92481291 |
| 49 | prepulse inhibition (GO:0060134) | 2.92162154 |
| 50 | positive regulation of receptor recycling (GO:0001921) | 2.89636308 |
| 51 | epithelial cell-cell adhesion (GO:0090136) | 2.89393338 |
| 52 | neuromuscular process controlling balance (GO:0050885) | 2.88473212 |
| 53 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.88436938 |
| 54 | alanine transport (GO:0032328) | 2.87969927 |
| 55 | exploration behavior (GO:0035640) | 2.87383189 |
| 56 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.82511357 |
| 57 | desmosome organization (GO:0002934) | 2.80490093 |
| 58 | cell-cell junction maintenance (GO:0045217) | 2.80316540 |
| 59 | gamma-aminobutyric acid transport (GO:0015812) | 2.79656782 |
| 60 | adenosine receptor signaling pathway (GO:0001973) | 2.79244266 |
| 61 | regulation of ARF GTPase activity (GO:0032312) | 2.79088918 |
| 62 | skin morphogenesis (GO:0043589) | 2.77316021 |
| 63 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.76650707 |
| 64 | cellular sodium ion homeostasis (GO:0006883) | 2.76390326 |
| 65 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.75162527 |
| 66 | regulation of extracellular matrix disassembly (GO:0010715) | 2.71140734 |
| 67 | cerebellar Purkinje cell layer development (GO:0021680) | 2.69793844 |
| 68 | regulation of cholesterol homeostasis (GO:2000188) | 2.69034674 |
| 69 | neuromuscular process controlling posture (GO:0050884) | 2.68668645 |
| 70 | response to laminar fluid shear stress (GO:0034616) | 2.64953591 |
| 71 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.63111988 |
| 72 | maternal placenta development (GO:0001893) | 2.63029771 |
| 73 | neuronal action potential propagation (GO:0019227) | 2.61706224 |
| 74 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.61349103 |
| 75 | positive regulation of extracellular matrix organization (GO:1903055) | 2.58872392 |
| 76 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.58529085 |
| 77 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.56962623 |
| 78 | mannose metabolic process (GO:0006013) | 2.56599701 |
| 79 | dendritic spine morphogenesis (GO:0060997) | 2.56487793 |
| 80 | potassium ion homeostasis (GO:0055075) | 2.55889491 |
| 81 | apoptotic cell clearance (GO:0043277) | 2.55308411 |
| 82 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.52901846 |
| 83 | apoptotic process involved in morphogenesis (GO:0060561) | 2.52721894 |
| 84 | stress fiber assembly (GO:0043149) | 2.51689364 |
| 85 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.51554666 |
| 86 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.50889104 |
| 87 | proline biosynthetic process (GO:0006561) | 2.50756103 |
| 88 | cortical actin cytoskeleton organization (GO:0030866) | 2.50719739 |
| 89 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.50486086 |
| 90 | alpha-linolenic acid metabolic process (GO:0036109) | 2.49250740 |
| 91 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.47957844 |
| 92 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.47612574 |
| 93 | pinocytosis (GO:0006907) | 2.47569169 |
| 94 | mating behavior (GO:0007617) | 2.46848946 |
| 95 | protein localization to endosome (GO:0036010) | 2.44464657 |
| 96 | glucose 6-phosphate metabolic process (GO:0051156) | 2.44249509 |
| 97 | cell communication involved in cardiac conduction (GO:0086065) | 2.44204392 |
| 98 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.43635506 |
| 99 | vesicle transport along microtubule (GO:0047496) | 2.42705401 |
| 100 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.41963932 |
| 101 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.38739076 |
| 102 | positive regulation of Rap GTPase activity (GO:0032854) | 2.37943449 |
| 103 | positive regulation of protein dephosphorylation (GO:0035307) | 2.37306856 |
| 104 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.37080686 |
| 105 | low-density lipoprotein particle clearance (GO:0034383) | 2.36997187 |
| 106 | regulation of neurotransmitter levels (GO:0001505) | 2.35713655 |
| 107 | neurotransmitter transport (GO:0006836) | 2.35272088 |
| 108 | nerve growth factor signaling pathway (GO:0038180) | 2.34840351 |
| 109 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.34289852 |
| 110 | myelin maintenance (GO:0043217) | 2.33334699 |
| 111 | cell volume homeostasis (GO:0006884) | 2.33104203 |
| 112 | long-term memory (GO:0007616) | 2.33025048 |
| 113 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.31993919 |
| 114 | regulation of synaptic plasticity (GO:0048167) | 2.31858504 |
| 115 | cAMP biosynthetic process (GO:0006171) | 2.31837313 |
| 116 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.31153272 |
| 117 | positive regulation of nuclease activity (GO:0032075) | 2.30525507 |
| 118 | adhesion of symbiont to host (GO:0044406) | 2.29805119 |
| 119 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.29795610 |
| 120 | negative regulation of cell size (GO:0045792) | 2.29739335 |
| 121 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.29713481 |
| 122 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.29287514 |
| 123 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.29106035 |
| 124 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.29041824 |
| 125 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.28709159 |
| 126 | amyloid precursor protein catabolic process (GO:0042987) | 2.28634107 |
| 127 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.28443942 |
| 128 | positive regulation of membrane potential (GO:0045838) | 2.28312788 |
| 129 | COPI coating of Golgi vesicle (GO:0048205) | 2.28017144 |
| 130 | Golgi transport vesicle coating (GO:0048200) | 2.28017144 |
| 131 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.27217713 |
| 132 | actin filament bundle organization (GO:0061572) | 2.27178247 |
| 133 | actin filament bundle assembly (GO:0051017) | 2.27178247 |
| 134 | regulation of Rap GTPase activity (GO:0032317) | 2.26708733 |
| 135 | protein targeting to plasma membrane (GO:0072661) | 2.26657094 |
| 136 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.26136820 |
| 137 | membrane depolarization during action potential (GO:0086010) | 2.25992381 |
| 138 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.25127117 |
| 139 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.25119072 |
| 140 | negative regulation of myotube differentiation (GO:0010832) | 2.24550839 |
| 141 | regulation of extracellular matrix organization (GO:1903053) | 2.24381699 |
| 142 | modulation by virus of host morphology or physiology (GO:0019048) | 2.23705388 |
| 143 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.22881606 |
| 144 | membrane repolarization (GO:0086009) | 2.22223889 |
| 145 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.21563252 |
| 146 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.21095869 |
| 147 | cortical cytoskeleton organization (GO:0030865) | 2.20985148 |
| 148 | peptidyl-proline hydroxylation (GO:0019511) | 2.19539412 |
| 149 | embryonic process involved in female pregnancy (GO:0060136) | 2.19038630 |
| 150 | response to auditory stimulus (GO:0010996) | 2.18489362 |
| 151 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.18230007 |
| 152 | positive regulation of vesicle fusion (GO:0031340) | 2.18139920 |
| 153 | suckling behavior (GO:0001967) | 2.18029162 |
| 154 | activation of JUN kinase activity (GO:0007257) | 2.17773620 |
| 155 | endocytic recycling (GO:0032456) | 2.17768873 |
| 156 | L-amino acid import (GO:0043092) | 2.17245777 |
| 157 | regulation of beta-amyloid formation (GO:1902003) | 2.16551524 |
| 158 | plasma membrane repair (GO:0001778) | 2.16308914 |
| 159 | modulation by symbiont of host cellular process (GO:0044068) | 2.15865351 |
| 160 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.15826169 |
| 161 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.15615955 |
| 162 | dopamine receptor signaling pathway (GO:0007212) | 2.14885470 |
| 163 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.14865308 |
| 164 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.14377751 |
| 165 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.14341998 |
| 166 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.13664242 |
| 167 | positive regulation of sodium ion transport (GO:0010765) | 2.13189418 |
| 168 | cellular response to glucagon stimulus (GO:0071377) | 2.12920892 |
| 169 | negative regulation of sodium ion transport (GO:0010766) | 2.12830361 |
| 170 | positive regulation of fibroblast migration (GO:0010763) | 2.12640548 |
| 171 | vesicle coating (GO:0006901) | 2.12529158 |
| 172 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.11776714 |
| 173 | response to fluid shear stress (GO:0034405) | 2.11405614 |
| 174 | signal complex assembly (GO:0007172) | 2.11078017 |
| 175 | pentose-phosphate shunt (GO:0006098) | 2.10885930 |
| 176 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.10324583 |
| 177 | glucose catabolic process (GO:0006007) | 2.10023111 |
| 178 | positive regulation of histone deacetylation (GO:0031065) | 2.09785718 |
| 179 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.09107259 |
| 180 | regulation of postsynaptic membrane potential (GO:0060078) | 2.08989729 |
| 181 | positive regulation of neurotransmitter transport (GO:0051590) | 2.08677878 |
| 182 | regulation of sodium ion transport (GO:0002028) | 2.07516217 |
| 183 | surfactant homeostasis (GO:0043129) | 2.06837871 |
| 184 | cellular response to catecholamine stimulus (GO:0071870) | 2.05516189 |
| 185 | cellular response to monoamine stimulus (GO:0071868) | 2.05516189 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.80307762 |
| 2 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.51108728 |
| 3 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.49825239 |
| 4 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.43537663 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.37036299 |
| 6 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.35324720 |
| 7 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.26359004 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.22198877 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.17249527 |
| 10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.98629074 |
| 11 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.98502410 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.89996310 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.89991122 |
| 14 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.89927011 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.89503593 |
| 16 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.88648436 |
| 17 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.87229619 |
| 18 | KDM2B_26808549_Chip-Seq_K562_Human | 1.86283547 |
| 19 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.84991408 |
| 20 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.82387235 |
| 21 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.78776934 |
| 22 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.78668230 |
| 23 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.76633578 |
| 24 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.76633578 |
| 25 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.75857418 |
| 26 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.72149727 |
| 27 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.70611101 |
| 28 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.69420587 |
| 29 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.69390369 |
| 30 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.68649898 |
| 31 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.68119763 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.65288062 |
| 33 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.62140454 |
| 34 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.61865904 |
| 35 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.60394382 |
| 36 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.59883080 |
| 37 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.59678831 |
| 38 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.56677938 |
| 39 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.56652303 |
| 40 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.55480905 |
| 41 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.54119715 |
| 42 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.53896052 |
| 43 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.53262787 |
| 44 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.52051134 |
| 45 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.51874765 |
| 46 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.51280878 |
| 47 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.50745694 |
| 48 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.50713556 |
| 49 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.48578637 |
| 50 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.48577115 |
| 51 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.47815430 |
| 52 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.44569987 |
| 53 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.44340872 |
| 54 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.44027495 |
| 55 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.43591252 |
| 56 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.41003327 |
| 57 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.39867168 |
| 58 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.39383962 |
| 59 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.37901990 |
| 60 | GATA1_19941826_ChIP-Seq_K562_Human | 1.37498539 |
| 61 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.36854424 |
| 62 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.36281707 |
| 63 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.36151583 |
| 64 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.35971844 |
| 65 | P68_20966046_ChIP-Seq_HELA_Human | 1.35688573 |
| 66 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.34850060 |
| 67 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.34481158 |
| 68 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.33629610 |
| 69 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.31641120 |
| 70 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.31385214 |
| 71 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.29414939 |
| 72 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.28684186 |
| 73 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.28374160 |
| 74 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.27922643 |
| 75 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.26931530 |
| 76 | SPI1_23127762_ChIP-Seq_K562_Human | 1.25193669 |
| 77 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.23720874 |
| 78 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.23477956 |
| 79 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.22829349 |
| 80 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.22811297 |
| 81 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.21069036 |
| 82 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.20982259 |
| 83 | GATA1_22025678_ChIP-Seq_K562_Human | 1.20821308 |
| 84 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.19032782 |
| 85 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.18596413 |
| 86 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18403697 |
| 87 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.17914748 |
| 88 | ATF3_27146783_Chip-Seq_COLON_Human | 1.17885575 |
| 89 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.17632447 |
| 90 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.17355877 |
| 91 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.17191114 |
| 92 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.16270828 |
| 93 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.16085612 |
| 94 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.15793936 |
| 95 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.15162897 |
| 96 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14601925 |
| 97 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.14545589 |
| 98 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.13421317 |
| 99 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.12755141 |
| 100 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10521571 |
| 101 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10354124 |
| 102 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.08159881 |
| 103 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.07857513 |
| 104 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07357120 |
| 105 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.07022888 |
| 106 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06602557 |
| 107 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06523525 |
| 108 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.06139743 |
| 109 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.05938043 |
| 110 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05236296 |
| 111 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.04488422 |
| 112 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.04461932 |
| 113 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04383218 |
| 114 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.02552280 |
| 115 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.02552280 |
| 116 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02390840 |
| 117 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.01473325 |
| 118 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01278085 |
| 119 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.01255146 |
| 120 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.01207376 |
| 121 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.00133502 |
| 122 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99576754 |
| 123 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.99139942 |
| 124 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.99090524 |
| 125 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98984677 |
| 126 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98133891 |
| 127 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97772355 |
| 128 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.97635884 |
| 129 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.97364555 |
| 130 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.97328533 |
| 131 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.96975826 |
| 132 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.96778292 |
| 133 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.96635744 |
| 134 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.95803761 |
| 135 | MAF_26560356_Chip-Seq_TH1_Human | 0.95515900 |
| 136 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.95153897 |
| 137 | GATA2_19941826_ChIP-Seq_K562_Human | 0.94733032 |
| 138 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.94314728 |
| 139 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93749717 |
| 140 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.92819715 |
| 141 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92263144 |
| 142 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92060616 |
| 143 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.91603167 |
| 144 | AR_19668381_ChIP-Seq_PC3_Human | 0.90754537 |
| 145 | MYC_22102868_ChIP-Seq_BL_Human | 0.90753638 |
| 146 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.90037956 |
| 147 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.89467382 |
| 148 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.89168914 |
| 149 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.88590532 |
| 150 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.87370899 |
| 151 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87367319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.34224285 |
| 2 | MP0002822_catalepsy | 3.12292873 |
| 3 | MP0002909_abnormal_adrenal_gland | 3.09686982 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 2.88432676 |
| 5 | MP0004858_abnormal_nervous_system | 2.74150844 |
| 6 | MP0003566_abnormal_cell_adhesion | 2.67424272 |
| 7 | MP0005451_abnormal_body_composition | 2.53744882 |
| 8 | MP0001849_ear_inflammation | 2.44540474 |
| 9 | MP0005076_abnormal_cell_differentiation | 2.43806832 |
| 10 | MP0009780_abnormal_chondrocyte_physiolo | 2.43776029 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.39297014 |
| 12 | MP0005409_darkened_coat_color | 2.27178536 |
| 13 | MP0004270_analgesia | 2.25822316 |
| 14 | MP0005257_abnormal_intraocular_pressure | 2.19276011 |
| 15 | MP0009745_abnormal_behavioral_response | 2.16539842 |
| 16 | MP0002064_seizures | 2.10251399 |
| 17 | MP0000013_abnormal_adipose_tissue | 2.08192682 |
| 18 | MP0002063_abnormal_learning/memory/cond | 2.07231064 |
| 19 | MP0003075_altered_response_to | 2.05125443 |
| 20 | MP0008961_abnormal_basal_metabolism | 2.04568014 |
| 21 | MP0004130_abnormal_muscle_cell | 2.02912214 |
| 22 | MP0003329_amyloid_beta_deposits | 2.01957570 |
| 23 | MP0003705_abnormal_hypodermis_morpholog | 2.00161888 |
| 24 | MP0003091_abnormal_cell_migration | 1.99057405 |
| 25 | MP0008260_abnormal_autophagy | 1.98135232 |
| 26 | MP0003279_aneurysm | 1.96899001 |
| 27 | MP0010234_abnormal_vibrissa_follicle | 1.90124417 |
| 28 | MP0005167_abnormal_blood-brain_barrier | 1.87969909 |
| 29 | MP0003172_abnormal_lysosome_physiology | 1.85600388 |
| 30 | MP0001968_abnormal_touch/_nociception | 1.81529578 |
| 31 | MP0003690_abnormal_glial_cell | 1.79455335 |
| 32 | MP0003303_peritoneal_inflammation | 1.78434988 |
| 33 | MP0003453_abnormal_keratinocyte_physiol | 1.76819975 |
| 34 | MP0005275_abnormal_skin_tensile | 1.76090309 |
| 35 | MP0005058_abnormal_lysosome_morphology | 1.74440800 |
| 36 | MP0009046_muscle_twitch | 1.74422695 |
| 37 | MP0004272_abnormal_basement_membrane | 1.69395708 |
| 38 | MP0008569_lethality_at_weaning | 1.63900890 |
| 39 | MP0001348_abnormal_lacrimal_gland | 1.60656228 |
| 40 | MP0002796_impaired_skin_barrier | 1.59278543 |
| 41 | MP0002837_dystrophic_cardiac_calcinosis | 1.59212949 |
| 42 | MP0001501_abnormal_sleep_pattern | 1.59063019 |
| 43 | MP0002877_abnormal_melanocyte_morpholog | 1.57802278 |
| 44 | MP0003191_abnormal_cellular_cholesterol | 1.57502032 |
| 45 | MP0003633_abnormal_nervous_system | 1.55210548 |
| 46 | MP0002060_abnormal_skin_morphology | 1.54305883 |
| 47 | MP0000604_amyloidosis | 1.51128904 |
| 48 | MP0010329_abnormal_lipoprotein_level | 1.50583758 |
| 49 | MP0004885_abnormal_endolymph | 1.49522236 |
| 50 | MP0002572_abnormal_emotion/affect_behav | 1.48297215 |
| 51 | MP0003283_abnormal_digestive_organ | 1.48000680 |
| 52 | MP0002272_abnormal_nervous_system | 1.47438843 |
| 53 | MP0000751_myopathy | 1.43906535 |
| 54 | MP0002733_abnormal_thermal_nociception | 1.40801563 |
| 55 | MP0005365_abnormal_bile_salt | 1.39661370 |
| 56 | MP0004811_abnormal_neuron_physiology | 1.39634150 |
| 57 | MP0002896_abnormal_bone_mineralization | 1.39229154 |
| 58 | MP0009278_abnormal_bone_marrow | 1.38968634 |
| 59 | MP0002139_abnormal_hepatobiliary_system | 1.38449362 |
| 60 | MP0003880_abnormal_central_pattern | 1.36768261 |
| 61 | MP0000537_abnormal_urethra_morphology | 1.36738220 |
| 62 | MP0004510_myositis | 1.36376433 |
| 63 | MP0002734_abnormal_mechanical_nocicepti | 1.34509536 |
| 64 | MP0003045_fibrosis | 1.34445652 |
| 65 | MP0001970_abnormal_pain_threshold | 1.31783419 |
| 66 | MP0005023_abnormal_wound_healing | 1.31236328 |
| 67 | MP0000003_abnormal_adipose_tissue | 1.30350096 |
| 68 | MP0009840_abnormal_foam_cell | 1.29587396 |
| 69 | MP0005535_abnormal_body_temperature | 1.28415426 |
| 70 | MP0008874_decreased_physiological_sensi | 1.27345203 |
| 71 | MP0000569_abnormal_digit_pigmentation | 1.27018230 |
| 72 | MP0002998_abnormal_bone_remodeling | 1.26694183 |
| 73 | MP0001486_abnormal_startle_reflex | 1.26009483 |
| 74 | MP0002736_abnormal_nociception_after | 1.25926815 |
| 75 | MP0005360_urolithiasis | 1.25390742 |
| 76 | MP0004947_skin_inflammation | 1.23530948 |
| 77 | MP0000767_abnormal_smooth_muscle | 1.22615571 |
| 78 | MP0002249_abnormal_larynx_morphology | 1.21877883 |
| 79 | MP0005670_abnormal_white_adipose | 1.19378640 |
| 80 | MP0002735_abnormal_chemical_nociception | 1.16842381 |
| 81 | MP0009384_cardiac_valve_regurgitation | 1.14785836 |
| 82 | MP0000733_abnormal_muscle_development | 1.12131733 |
| 83 | MP0003879_abnormal_hair_cell | 1.10554736 |
| 84 | MP0003436_decreased_susceptibility_to | 1.09930544 |
| 85 | MP0005503_abnormal_tendon_morphology | 1.09679083 |
| 86 | MP0005083_abnormal_biliary_tract | 1.09231067 |
| 87 | MP0005501_abnormal_skin_physiology | 1.06280457 |
| 88 | MP0000678_abnormal_parathyroid_gland | 1.05375495 |
| 89 | MP0002090_abnormal_vision | 1.05278663 |
| 90 | MP0002118_abnormal_lipid_homeostasis | 1.04525782 |
| 91 | MP0003631_nervous_system_phenotype | 1.03895861 |
| 92 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.03062551 |
| 93 | MP0000858_altered_metastatic_potential | 1.01883306 |
| 94 | MP0005375_adipose_tissue_phenotype | 1.01016742 |
| 95 | MP0005166_decreased_susceptibility_to | 1.00826086 |
| 96 | MP0005623_abnormal_meninges_morphology | 1.00096089 |
| 97 | MP0000681_abnormal_thyroid_gland | 0.99977148 |
| 98 | MP0005085_abnormal_gallbladder_physiolo | 0.99923334 |
| 99 | MP0003252_abnormal_bile_duct | 0.99011294 |
| 100 | MP0005423_abnormal_somatic_nervous | 0.98852099 |
| 101 | MP0001765_abnormal_ion_homeostasis | 0.97457489 |
| 102 | MP0004782_abnormal_surfactant_physiolog | 0.97219352 |
| 103 | MP0004381_abnormal_hair_follicle | 0.96924235 |
| 104 | MP0005508_abnormal_skeleton_morphology | 0.93527463 |
| 105 | MP0004264_abnormal_extraembryonic_tissu | 0.92991786 |
| 106 | MP0000747_muscle_weakness | 0.91780111 |
| 107 | MP0004924_abnormal_behavior | 0.89652958 |
| 108 | MP0005386_behavior/neurological_phenoty | 0.89652958 |
| 109 | MP0002067_abnormal_sensory_capabilities | 0.89424066 |
| 110 | MP0002078_abnormal_glucose_homeostasis | 0.89163142 |
| 111 | MP0008872_abnormal_physiological_respon | 0.86237604 |
| 112 | MP0000955_abnormal_spinal_cord | 0.85856238 |
| 113 | MP0002971_abnormal_brown_adipose | 0.85570717 |
| 114 | MP0001958_emphysema | 0.84766032 |
| 115 | MP0004233_abnormal_muscle_weight | 0.84454303 |
| 116 | MP0005621_abnormal_cell_physiology | 0.84436143 |
| 117 | MP0001440_abnormal_grooming_behavior | 0.84332245 |
| 118 | MP0000467_abnormal_esophagus_morphology | 0.83549539 |
| 119 | MP0000920_abnormal_myelination | 0.82905103 |
| 120 | MP0000579_abnormal_nail_morphology | 0.82784769 |
| 121 | MP0001851_eye_inflammation | 0.80848634 |
| 122 | MP0000462_abnormal_digestive_system | 0.80761605 |
| 123 | MP0004043_abnormal_pH_regulation | 0.80512917 |
| 124 | MP0002066_abnormal_motor_capabilities/c | 0.80315532 |
| 125 | MP0001533_abnormal_skeleton_physiology | 0.80072957 |
| 126 | MP0004084_abnormal_cardiac_muscle | 0.79894521 |
| 127 | MP0001216_abnormal_epidermal_layer | 0.79590895 |
| 128 | MP0004036_abnormal_muscle_relaxation | 0.78663880 |
| 129 | MP0001915_intracranial_hemorrhage | 0.77738779 |
| 130 | MP0010352_gastrointestinal_tract_polyps | 0.77240974 |
| 131 | MP0005646_abnormal_pituitary_gland | 0.76249924 |
| 132 | MP0005666_abnormal_adipose_tissue | 0.74958283 |
| 133 | MP0003634_abnormal_glial_cell | 0.74939698 |
| 134 | MP0004085_abnormal_heartbeat | 0.74752686 |
| 135 | MP0002557_abnormal_social/conspecific_i | 0.74638744 |
| 136 | MP0005390_skeleton_phenotype | 0.73715459 |
| 137 | MP0004087_abnormal_muscle_fiber | 0.73457400 |
| 138 | MP0000759_abnormal_skeletal_muscle | 0.73417960 |
| 139 | MP0003828_pulmonary_edema | 0.72991076 |
| 140 | MP0002098_abnormal_vibrissa_morphology | 0.72925490 |
| 141 | MP0002089_abnormal_postnatal_growth/wei | 0.72684373 |
| 142 | MP0002970_abnormal_white_adipose | 0.72437569 |
| 143 | MP0010368_abnormal_lymphatic_system | 0.71985284 |
| 144 | MP0003183_abnormal_peptide_metabolism | 0.71936670 |
| 145 | MP0005464_abnormal_platelet_physiology | 0.71793781 |
| 146 | MP0000534_abnormal_ureter_morphology | 0.71261386 |
| 147 | MP0002069_abnormal_eating/drinking_beha | 0.71194605 |
| 148 | MP0008438_abnormal_cutaneous_collagen | 0.70616969 |
| 149 | MP0006138_congestive_heart_failure | 0.70584046 |
| 150 | MP0001756_abnormal_urination | 0.69871918 |
| 151 | MP0001177_atelectasis | 0.68950486 |
| 152 | MP0002269_muscular_atrophy | 0.68142595 |
| 153 | MP0008875_abnormal_xenobiotic_pharmacok | 0.68117420 |
| 154 | MP0004185_abnormal_adipocyte_glucose | 0.67949548 |
| 155 | MP0002009_preneoplasia | 0.67844567 |
| 156 | MP0009931_abnormal_skin_appearance | 0.67759910 |
| 157 | MP0010630_abnormal_cardiac_muscle | 0.65261236 |
| 158 | MP0010771_integument_phenotype | 0.65053312 |
| 159 | MP0005595_abnormal_vascular_smooth | 0.64468449 |
| 160 | MP0000377_abnormal_hair_follicle | 0.61653525 |
| 161 | MP0002166_altered_tumor_susceptibility | 0.61500309 |
| 162 | MP0003115_abnormal_respiratory_system | 0.61152325 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 4.24098317 |
| 2 | Protrusio acetabuli (HP:0003179) | 3.89367149 |
| 3 | Premature rupture of membranes (HP:0001788) | 3.59793636 |
| 4 | Visual hallucinations (HP:0002367) | 3.47540672 |
| 5 | Action tremor (HP:0002345) | 3.19296332 |
| 6 | Focal motor seizures (HP:0011153) | 3.17261006 |
| 7 | Broad face (HP:0000283) | 3.16731773 |
| 8 | Supranuclear gaze palsy (HP:0000605) | 3.15836012 |
| 9 | Papilledema (HP:0001085) | 3.09643589 |
| 10 | Focal seizures (HP:0007359) | 2.97884902 |
| 11 | Vertebral compression fractures (HP:0002953) | 2.97095672 |
| 12 | Cervical subluxation (HP:0003308) | 2.93262449 |
| 13 | Obstructive sleep apnea (HP:0002870) | 2.89475303 |
| 14 | Hemiplegia (HP:0002301) | 2.79364164 |
| 15 | Cerebral aneurysm (HP:0004944) | 2.79066414 |
| 16 | Postural instability (HP:0002172) | 2.76952388 |
| 17 | Depression (HP:0000716) | 2.76101293 |
| 18 | Bundle branch block (HP:0011710) | 2.73468398 |
| 19 | J-shaped sella turcica (HP:0002680) | 2.70723460 |
| 20 | Upper limb amyotrophy (HP:0009129) | 2.63142859 |
| 21 | Distal upper limb amyotrophy (HP:0007149) | 2.63142859 |
| 22 | Increased connective tissue (HP:0009025) | 2.61679450 |
| 23 | Shallow orbits (HP:0000586) | 2.59992996 |
| 24 | Ankle clonus (HP:0011448) | 2.59676146 |
| 25 | Thin bony cortex (HP:0002753) | 2.59488024 |
| 26 | Flat acetabular roof (HP:0003180) | 2.53488038 |
| 27 | Torticollis (HP:0000473) | 2.53349293 |
| 28 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.51407850 |
| 29 | Hyperacusis (HP:0010780) | 2.48527849 |
| 30 | Abnormality of the lower motor neuron (HP:0002366) | 2.47809934 |
| 31 | Dysmetric saccades (HP:0000641) | 2.42563727 |
| 32 | Ulnar bowing (HP:0003031) | 2.41699491 |
| 33 | Enlarged penis (HP:0000040) | 2.39766335 |
| 34 | Insomnia (HP:0100785) | 2.37151710 |
| 35 | Atrophic scars (HP:0001075) | 2.36586747 |
| 36 | Impaired social interactions (HP:0000735) | 2.36493398 |
| 37 | Abnormal social behavior (HP:0012433) | 2.36493398 |
| 38 | Distal lower limb amyotrophy (HP:0008944) | 2.35966386 |
| 39 | Dysostosis multiplex (HP:0000943) | 2.35142934 |
| 40 | Ventricular fibrillation (HP:0001663) | 2.33769851 |
| 41 | Resting tremor (HP:0002322) | 2.33667699 |
| 42 | Macroorchidism (HP:0000053) | 2.33507505 |
| 43 | Deep venous thrombosis (HP:0002625) | 2.33065737 |
| 44 | Fragile skin (HP:0001030) | 2.32166531 |
| 45 | Increased cerebral lipofuscin (HP:0011813) | 2.30988337 |
| 46 | Annular pancreas (HP:0001734) | 2.29545418 |
| 47 | Intention tremor (HP:0002080) | 2.28782684 |
| 48 | Mucopolysacchariduria (HP:0008155) | 2.26708891 |
| 49 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.26708891 |
| 50 | Hand muscle atrophy (HP:0009130) | 2.26681946 |
| 51 | Hypercortisolism (HP:0001578) | 2.23258357 |
| 52 | Urinary urgency (HP:0000012) | 2.23202755 |
| 53 | Focal dystonia (HP:0004373) | 2.22114818 |
| 54 | Wormian bones (HP:0002645) | 2.22101394 |
| 55 | Mitral regurgitation (HP:0001653) | 2.22051167 |
| 56 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.21868419 |
| 57 | Short nail (HP:0001799) | 2.19679644 |
| 58 | Craniofacial dystonia (HP:0012179) | 2.18239379 |
| 59 | Poor eye contact (HP:0000817) | 2.17321222 |
| 60 | Blue sclerae (HP:0000592) | 2.16013223 |
| 61 | Pointed chin (HP:0000307) | 2.15352176 |
| 62 | Generalized tonic-clonic seizures (HP:0002069) | 2.14797940 |
| 63 | Vascular tortuosity (HP:0004948) | 2.14731764 |
| 64 | Spinal rigidity (HP:0003306) | 2.14691093 |
| 65 | Arterial tortuosity (HP:0005116) | 2.14039157 |
| 66 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.10822442 |
| 67 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.10319891 |
| 68 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.10319891 |
| 69 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.10319891 |
| 70 | Abnormality of the Achilles tendon (HP:0005109) | 2.09835825 |
| 71 | Bladder diverticulum (HP:0000015) | 2.09525761 |
| 72 | Achilles tendon contracture (HP:0001771) | 2.09105926 |
| 73 | Axonal loss (HP:0003447) | 2.08036617 |
| 74 | Advanced eruption of teeth (HP:0006288) | 2.08019610 |
| 75 | Striae distensae (HP:0001065) | 2.07779908 |
| 76 | Distal lower limb muscle weakness (HP:0009053) | 2.05896233 |
| 77 | Anxiety (HP:0000739) | 2.05485281 |
| 78 | Disproportionate tall stature (HP:0001519) | 2.04479734 |
| 79 | Polygenic inheritance (HP:0010982) | 2.03162416 |
| 80 | Abnormality of glycolipid metabolism (HP:0010969) | 2.02623187 |
| 81 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.02623187 |
| 82 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.02623187 |
| 83 | Asymmetry of the thorax (HP:0001555) | 2.02466717 |
| 84 | Rapidly progressive (HP:0003678) | 2.02261519 |
| 85 | Long toe (HP:0010511) | 2.02120570 |
| 86 | Biconcave vertebral bodies (HP:0004586) | 2.01944186 |
| 87 | Abnormal eating behavior (HP:0100738) | 2.01065221 |
| 88 | Increased variability in muscle fiber diameter (HP:0003557) | 1.99959828 |
| 89 | Lymphangioma (HP:0100764) | 1.98783362 |
| 90 | Nuclear cataract (HP:0100018) | 1.98716519 |
| 91 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.97918187 |
| 92 | Atonic seizures (HP:0010819) | 1.97206181 |
| 93 | Premature skin wrinkling (HP:0100678) | 1.96811843 |
| 94 | Complement deficiency (HP:0004431) | 1.95664927 |
| 95 | Agitation (HP:0000713) | 1.94837899 |
| 96 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.93756749 |
| 97 | Osteolytic defects of the hand bones (HP:0009699) | 1.93756749 |
| 98 | Cerebral inclusion bodies (HP:0100314) | 1.93597190 |
| 99 | Neuronal loss in central nervous system (HP:0002529) | 1.93362932 |
| 100 | Hemorrhage of the eye (HP:0011885) | 1.92501964 |
| 101 | Broad metatarsal (HP:0001783) | 1.92113640 |
| 102 | Dilatation of the ascending aorta (HP:0005111) | 1.91241066 |
| 103 | Global brain atrophy (HP:0002283) | 1.90684546 |
| 104 | Lower limb asymmetry (HP:0100559) | 1.90625579 |
| 105 | Truncal ataxia (HP:0002078) | 1.90240417 |
| 106 | Atrioventricular block (HP:0001678) | 1.90236389 |
| 107 | Status epilepticus (HP:0002133) | 1.90217814 |
| 108 | Dysdiadochokinesis (HP:0002075) | 1.89817673 |
| 109 | Absence seizures (HP:0002121) | 1.89570102 |
| 110 | Asymmetric septal hypertrophy (HP:0001670) | 1.89133177 |
| 111 | Aneurysm (HP:0002617) | 1.87965790 |
| 112 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.87092475 |
| 113 | Increased CSF protein (HP:0002922) | 1.86717631 |
| 114 | Hyperparathyroidism (HP:0000843) | 1.86445177 |
| 115 | Genu recurvatum (HP:0002816) | 1.86322792 |
| 116 | Heart block (HP:0012722) | 1.85105065 |
| 117 | Elfin facies (HP:0004428) | 1.85103550 |
| 118 | Back pain (HP:0003418) | 1.84815345 |
| 119 | Stridor (HP:0010307) | 1.84375796 |
| 120 | Scanning speech (HP:0002168) | 1.84261894 |
| 121 | Dysmetria (HP:0001310) | 1.83893452 |
| 122 | Neurofibrillary tangles (HP:0002185) | 1.83382257 |
| 123 | Natal tooth (HP:0000695) | 1.81992322 |
| 124 | Aortic aneurysm (HP:0004942) | 1.81799398 |
| 125 | Aortic dissection (HP:0002647) | 1.81711566 |
| 126 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.81140050 |
| 127 | Deformed sella turcica (HP:0002681) | 1.80599762 |
| 128 | Abnormality of the periventricular white matter (HP:0002518) | 1.80037451 |
| 129 | Ketoacidosis (HP:0001993) | 1.79757300 |
| 130 | Mitral valve prolapse (HP:0001634) | 1.78927648 |
| 131 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.78781001 |
| 132 | Bradykinesia (HP:0002067) | 1.78395553 |
| 133 | Bronchomalacia (HP:0002780) | 1.77797291 |
| 134 | Ankle contracture (HP:0006466) | 1.77634121 |
| 135 | Abnormal ossification of hand bones (HP:0005921) | 1.77480039 |
| 136 | Abnormality of carpal bone ossification (HP:0006257) | 1.77306355 |
| 137 | Spinal canal stenosis (HP:0003416) | 1.76838945 |
| 138 | Abnormality of the thoracic spine (HP:0100711) | 1.76547767 |
| 139 | Loss of speech (HP:0002371) | 1.76228400 |
| 140 | Impaired smooth pursuit (HP:0007772) | 1.74848416 |
| 141 | Ankyloglossia (HP:0010296) | 1.74540601 |
| 142 | Turricephaly (HP:0000262) | 1.73638820 |
| 143 | Mutism (HP:0002300) | 1.73511012 |
| 144 | Lower limb amyotrophy (HP:0007210) | 1.72655273 |
| 145 | Long palpebral fissure (HP:0000637) | 1.72529616 |
| 146 | Abnormal atrioventricular conduction (HP:0005150) | 1.72242125 |
| 147 | Spinal cord compression (HP:0002176) | 1.72130233 |
| 148 | Mitral stenosis (HP:0001718) | 1.71702895 |
| 149 | Hematochezia (HP:0002573) | 1.71284007 |
| 150 | Insidious onset (HP:0003587) | 1.69388983 |
| 151 | Termporal pattern (HP:0011008) | 1.69388983 |
| 152 | Germ cell neoplasia (HP:0100728) | 1.68771403 |
| 153 | Hyperextensible skin (HP:0000974) | 1.68423715 |
| 154 | Ketosis (HP:0001946) | 1.68278109 |
| 155 | Bowel diverticulosis (HP:0005222) | 1.67967900 |
| 156 | Neonatal onset (HP:0003623) | 1.67836482 |
| 157 | Xanthomatosis (HP:0000991) | 1.67245821 |
| 158 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.66814619 |
| 159 | Interstitial pulmonary disease (HP:0006530) | 1.66040643 |
| 160 | Postural tremor (HP:0002174) | 1.65893073 |
| 161 | Joint laxity (HP:0001388) | 1.65618193 |
| 162 | Pheochromocytoma (HP:0002666) | 1.65348287 |
| 163 | Megalencephaly (HP:0001355) | 1.64900788 |
| 164 | Abnormality of complement system (HP:0005339) | 1.64563301 |
| 165 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.64196555 |
| 166 | Spondylolisthesis (HP:0003302) | 1.64039729 |
| 167 | Hammertoe (HP:0001765) | 1.63240226 |
| 168 | Congenital glaucoma (HP:0001087) | 1.63087591 |
| 169 | Joint stiffness (HP:0001387) | 1.63030386 |
| 170 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.62224389 |
| 171 | Coxa vara (HP:0002812) | 1.61182158 |
| 172 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.59915846 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.91223019 |
| 2 | PRPF4B | 2.93663643 |
| 3 | SMG1 | 2.87725440 |
| 4 | MAP3K9 | 2.74377085 |
| 5 | PRKD3 | 2.63895405 |
| 6 | IRAK3 | 2.57061710 |
| 7 | ICK | 2.56047687 |
| 8 | PKN2 | 2.53968424 |
| 9 | CAMKK1 | 2.47290958 |
| 10 | DAPK2 | 2.41099562 |
| 11 | NTRK3 | 2.39024836 |
| 12 | RIPK1 | 2.34116425 |
| 13 | EPHA4 | 2.32129820 |
| 14 | KSR2 | 2.31066255 |
| 15 | CDK12 | 2.20815882 |
| 16 | LMTK2 | 2.10991609 |
| 17 | NTRK1 | 2.08587343 |
| 18 | EEF2K | 1.88605202 |
| 19 | EPHA2 | 1.76056624 |
| 20 | ERN1 | 1.72130257 |
| 21 | PAK6 | 1.69549541 |
| 22 | MINK1 | 1.69351117 |
| 23 | MAP3K2 | 1.64909773 |
| 24 | PRKCH | 1.54409476 |
| 25 | MAP3K13 | 1.51705419 |
| 26 | PDGFRA | 1.47434074 |
| 27 | RET | 1.46923121 |
| 28 | CAMKK2 | 1.43022208 |
| 29 | FES | 1.41853499 |
| 30 | SCYL2 | 1.41174895 |
| 31 | MAP3K4 | 1.38301629 |
| 32 | TAOK1 | 1.36126136 |
| 33 | RIPK4 | 1.32055973 |
| 34 | STK38 | 1.32026659 |
| 35 | TESK1 | 1.27404455 |
| 36 | MAP2K4 | 1.25250177 |
| 37 | MTOR | 1.22140529 |
| 38 | CAMK1G | 1.20761133 |
| 39 | PTK6 | 1.20436145 |
| 40 | SIK1 | 1.20019623 |
| 41 | SIK2 | 1.18053511 |
| 42 | LATS2 | 1.17828296 |
| 43 | PAK4 | 1.15599221 |
| 44 | MAP3K1 | 1.13703444 |
| 45 | SGK3 | 1.10288179 |
| 46 | ALK | 1.09612561 |
| 47 | NME2 | 1.09465651 |
| 48 | MAP3K7 | 1.05562884 |
| 49 | CAMK1D | 1.05047989 |
| 50 | DAPK1 | 1.04677358 |
| 51 | CDK5 | 1.03815364 |
| 52 | MST1R | 1.02864824 |
| 53 | MAP2K3 | 1.01237228 |
| 54 | TYRO3 | 0.99323729 |
| 55 | JAK1 | 0.96824838 |
| 56 | NTRK2 | 0.95510214 |
| 57 | DMPK | 0.95435611 |
| 58 | PDPK1 | 0.95048571 |
| 59 | TAOK3 | 0.94518472 |
| 60 | FRK | 0.94383325 |
| 61 | PDK1 | 0.92670414 |
| 62 | MAP3K3 | 0.88411341 |
| 63 | EPHB1 | 0.87303883 |
| 64 | TNK2 | 0.86609345 |
| 65 | BMX | 0.85600372 |
| 66 | TAOK2 | 0.85169892 |
| 67 | STK11 | 0.83179234 |
| 68 | MAP3K10 | 0.82133203 |
| 69 | RPS6KA2 | 0.81927609 |
| 70 | TTN | 0.80838989 |
| 71 | FGFR2 | 0.79554060 |
| 72 | CAMK1 | 0.78028057 |
| 73 | JAK2 | 0.76720459 |
| 74 | ARAF | 0.76682447 |
| 75 | PIM2 | 0.75516671 |
| 76 | UHMK1 | 0.74881954 |
| 77 | PAK2 | 0.74450266 |
| 78 | MAP3K6 | 0.74357189 |
| 79 | TBK1 | 0.73065597 |
| 80 | PINK1 | 0.72599769 |
| 81 | IRAK2 | 0.70220768 |
| 82 | NEK1 | 0.69128776 |
| 83 | SGK494 | 0.68991557 |
| 84 | SGK223 | 0.68991557 |
| 85 | MAPK11 | 0.67905535 |
| 86 | LRRK2 | 0.67387740 |
| 87 | PHKG2 | 0.66149715 |
| 88 | PHKG1 | 0.66149715 |
| 89 | WNK1 | 0.65373350 |
| 90 | FGFR4 | 0.62577081 |
| 91 | MAP3K11 | 0.61787050 |
| 92 | PTK2B | 0.61621545 |
| 93 | FGFR3 | 0.61395829 |
| 94 | MAPK12 | 0.60911672 |
| 95 | RPS6KC1 | 0.60722638 |
| 96 | RPS6KL1 | 0.60722638 |
| 97 | SGK2 | 0.59952570 |
| 98 | CAMK4 | 0.59881115 |
| 99 | MAP2K2 | 0.59221793 |
| 100 | MARK2 | 0.59115964 |
| 101 | MAP3K12 | 0.59032171 |
| 102 | HIPK2 | 0.58078270 |
| 103 | CDC42BPA | 0.57676029 |
| 104 | PRKD1 | 0.56142490 |
| 105 | PAK3 | 0.55828722 |
| 106 | MET | 0.55454856 |
| 107 | PTK2 | 0.53823283 |
| 108 | DAPK3 | 0.53424766 |
| 109 | MATK | 0.53373873 |
| 110 | MAP3K14 | 0.51813117 |
| 111 | RAF1 | 0.51532081 |
| 112 | ZAP70 | 0.51401776 |
| 113 | FER | 0.51030253 |
| 114 | PDGFRB | 0.50823180 |
| 115 | MOS | 0.50756555 |
| 116 | TYK2 | 0.50562015 |
| 117 | MAP2K1 | 0.50334104 |
| 118 | DDR2 | 0.48043865 |
| 119 | FYN | 0.47944884 |
| 120 | TESK2 | 0.46336294 |
| 121 | ILK | 0.45509067 |
| 122 | MAP2K7 | 0.44184314 |
| 123 | BCKDK | 0.43957626 |
| 124 | CDK6 | 0.43768013 |
| 125 | CSF1R | 0.43354285 |
| 126 | MAPKAPK3 | 0.43078035 |
| 127 | SGK1 | 0.42368714 |
| 128 | PRKG2 | 0.41305068 |
| 129 | KSR1 | 0.41274622 |
| 130 | RPS6KB2 | 0.40577743 |
| 131 | HCK | 0.40442728 |
| 132 | GRK5 | 0.40122448 |
| 133 | RPS6KA3 | 0.39755040 |
| 134 | BRAF | 0.39364896 |
| 135 | ROCK2 | 0.38681500 |
| 136 | TGFBR2 | 0.38674825 |
| 137 | NEK9 | 0.38403121 |
| 138 | TRPM7 | 0.38163289 |
| 139 | IRAK4 | 0.38082730 |
| 140 | RPS6KA6 | 0.37709232 |
| 141 | ROCK1 | 0.37170688 |
| 142 | PRKCG | 0.36732003 |
| 143 | PRKD2 | 0.36521457 |
| 144 | PRKCZ | 0.36244215 |
| 145 | MAPK10 | 0.34108939 |
| 146 | MAPK7 | 0.33908013 |
| 147 | MAP3K8 | 0.33842315 |
| 148 | NEK6 | 0.33655128 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.48109499 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.82019735 |
| 3 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.03632142 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.02781784 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.01559225 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.94043180 |
| 7 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.85695908 |
| 8 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.72109434 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.62536996 |
| 10 | Circadian entrainment_Homo sapiens_hsa04713 | 1.62140478 |
| 11 | Insulin secretion_Homo sapiens_hsa04911 | 1.61787020 |
| 12 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.56417737 |
| 13 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.56111217 |
| 14 | GABAergic synapse_Homo sapiens_hsa04727 | 1.53635113 |
| 15 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.53079332 |
| 16 | Long-term potentiation_Homo sapiens_hsa04720 | 1.52357437 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 1.46876711 |
| 18 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.41142815 |
| 19 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.40829010 |
| 20 | Morphine addiction_Homo sapiens_hsa05032 | 1.39085097 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.36826483 |
| 22 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.36505976 |
| 23 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.35040014 |
| 24 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.33035113 |
| 25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.32759281 |
| 26 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.30989921 |
| 27 | Bile secretion_Homo sapiens_hsa04976 | 1.30678003 |
| 28 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.29742773 |
| 29 | Bladder cancer_Homo sapiens_hsa05219 | 1.29056632 |
| 30 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.24753995 |
| 31 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.24096106 |
| 32 | Renin secretion_Homo sapiens_hsa04924 | 1.23216055 |
| 33 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.23145495 |
| 34 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.20076688 |
| 35 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.19197771 |
| 36 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.19037915 |
| 37 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.18768868 |
| 38 | Glioma_Homo sapiens_hsa05214 | 1.17515274 |
| 39 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.17369710 |
| 40 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.15585210 |
| 41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.15174550 |
| 42 | Cocaine addiction_Homo sapiens_hsa05030 | 1.12506674 |
| 43 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.09600144 |
| 44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.09536279 |
| 45 | Galactose metabolism_Homo sapiens_hsa00052 | 1.08876735 |
| 46 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.07355730 |
| 47 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.04666947 |
| 48 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.04190510 |
| 49 | Thyroid cancer_Homo sapiens_hsa05216 | 1.01957598 |
| 50 | Nicotine addiction_Homo sapiens_hsa05033 | 0.98010702 |
| 51 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.97040490 |
| 52 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.96207920 |
| 53 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.96140539 |
| 54 | Gap junction_Homo sapiens_hsa04540 | 0.95515848 |
| 55 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95461288 |
| 56 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.94652186 |
| 57 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.92221297 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88387380 |
| 59 | Insulin resistance_Homo sapiens_hsa04931 | 0.87789619 |
| 60 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.87193485 |
| 61 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.86972050 |
| 62 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.86936230 |
| 63 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.86639631 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86407968 |
| 65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.86320330 |
| 66 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.85517676 |
| 67 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.85433679 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.84989190 |
| 69 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.84221593 |
| 70 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.83399856 |
| 71 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.83193205 |
| 72 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.82225435 |
| 73 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.82217750 |
| 74 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.82177124 |
| 75 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.81253011 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81183774 |
| 77 | Prostate cancer_Homo sapiens_hsa05215 | 0.80262719 |
| 78 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.80026764 |
| 79 | Lysine degradation_Homo sapiens_hsa00310 | 0.79727741 |
| 80 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.79151671 |
| 81 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.79084297 |
| 82 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.78976882 |
| 83 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.78645959 |
| 84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77976211 |
| 85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.77707869 |
| 86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.77517145 |
| 87 | Adherens junction_Homo sapiens_hsa04520 | 0.74837234 |
| 88 | Long-term depression_Homo sapiens_hsa04730 | 0.74478132 |
| 89 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.73909486 |
| 90 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.73619374 |
| 91 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.72922577 |
| 92 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71289228 |
| 93 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.69258860 |
| 94 | Lysosome_Homo sapiens_hsa04142 | 0.69164960 |
| 95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68891746 |
| 96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.68626791 |
| 97 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.68169331 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67637566 |
| 99 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.67034497 |
| 100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.66581104 |
| 101 | Platelet activation_Homo sapiens_hsa04611 | 0.64769675 |
| 102 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.64553647 |
| 103 | Prion diseases_Homo sapiens_hsa05020 | 0.63614363 |
| 104 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62402986 |
| 105 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.61976852 |
| 106 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.61920492 |
| 107 | Endometrial cancer_Homo sapiens_hsa05213 | 0.61888746 |
| 108 | Endocytosis_Homo sapiens_hsa04144 | 0.61437065 |
| 109 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61095590 |
| 110 | Salmonella infection_Homo sapiens_hsa05132 | 0.61062106 |
| 111 | Taste transduction_Homo sapiens_hsa04742 | 0.60452095 |
| 112 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.60182411 |
| 113 | Hepatitis B_Homo sapiens_hsa05161 | 0.58782837 |
| 114 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58770933 |
| 115 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57685014 |
| 116 | ABC transporters_Homo sapiens_hsa02010 | 0.57609789 |
| 117 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57527987 |
| 118 | Melanogenesis_Homo sapiens_hsa04916 | 0.57503668 |
| 119 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.57499789 |
| 120 | Shigellosis_Homo sapiens_hsa05131 | 0.55298331 |
| 121 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.54887366 |
| 122 | Apoptosis_Homo sapiens_hsa04210 | 0.54770355 |
| 123 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54325177 |
| 124 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.53572660 |
| 125 | Amoebiasis_Homo sapiens_hsa05146 | 0.52966653 |
| 126 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.52666034 |
| 127 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52039439 |
| 128 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51773259 |
| 129 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.51699594 |
| 130 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.51117975 |
| 131 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50431694 |
| 132 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.50294733 |
| 133 | Axon guidance_Homo sapiens_hsa04360 | 0.48590382 |
| 134 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.48538901 |
| 135 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.48465859 |
| 136 | Focal adhesion_Homo sapiens_hsa04510 | 0.47433592 |
| 137 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46289410 |
| 138 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46160751 |
| 139 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.46008034 |
| 140 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.45658363 |
| 141 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.44865439 |

